Search research articles
Contact Us
Filters
Showing results (431-440 of 494) with videos related to
Page
of 50
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
December 20, 2012
Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function
Laura E Crotty Alexander, Kathryn Akong-Moore, Stephanie Feldstein, et al.
Journal of Medicinal Chemistry
|
March 25, 2017
Discovery of 4-((3'R,4'S,5'R)-6″-Chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2″-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3″-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development
Angelo Aguilar, Jianfeng Lu, Liu Liu, et al.
ACR Open Rheumatology
|
November 1, 2022
A Diagnostic Prediction Model to Distinguish Multisystem Inflammatory Syndrome in Children
Matthew T Clark, Danielle A Rankin, Lauren S Peetluk, et al.
Nature Chemical Biology
|
February 2, 2023
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
Atsunori Kaneshige, Longchuan Bai, Mi Wang, et al.
British Journal of Cancer
|
May 17, 2018
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers
Jorge Cortes, Kenji Tamura, Daniel J DeAngelo, et al.
Science (New York, N.Y.)
|
October 1, 2005
Bats are natural reservoirs of SARS-like coronaviruses
Wendong Li, Zhengli Shi, Meng Yu, et al.
Journal of Medicinal Chemistry
|
August 22, 2025
Discovery of a Novel Series of <i>iso</i>-Indolinone-Based Glutarimides as Highly Efficacious and Selective IKZF2 Molecular Glue Degraders
Xuqing Zhang, Harshil Dhruv, Qiaolin Deng, et al.
Journal of Medicinal Chemistry
|
March 20, 2010
Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication
Renato T Skerlj, Gary J Bridger, Al Kaller, et al.
Journal of Medicinal Chemistry
|
March 30, 2011
A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment
Qian Cai, Haiying Sun, Yuefeng Peng, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 8, 2011
Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication
Renato Skerlj, Gary Bridger, Ernest McEachern, et al.
Page
of 50
Search research articles
Search
Showing results (431-440 of 494) with videos related to
Sort By:
Page
of 50
Journal of Molecular Medicine (Berlin, Germany)
|
December 20, 2012
Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function
Laura E Crotty Alexander, Kathryn Akong-Moore, Stephanie Feldstein, et al.
Journal of Medicinal Chemistry
|
March 25, 2017
Discovery of 4-((3'R,4'S,5'R)-6″-Chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2″-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3″-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development
Angelo Aguilar, Jianfeng Lu, Liu Liu, et al.
ACR Open Rheumatology
|
November 1, 2022
A Diagnostic Prediction Model to Distinguish Multisystem Inflammatory Syndrome in Children
Matthew T Clark, Danielle A Rankin, Lauren S Peetluk, et al.
Nature Chemical Biology
|
February 2, 2023
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
Atsunori Kaneshige, Longchuan Bai, Mi Wang, et al.
British Journal of Cancer
|
May 17, 2018
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers
Jorge Cortes, Kenji Tamura, Daniel J DeAngelo, et al.
Science (New York, N.Y.)
|
October 1, 2005
Bats are natural reservoirs of SARS-like coronaviruses
Wendong Li, Zhengli Shi, Meng Yu, et al.
Journal of Medicinal Chemistry
|
August 22, 2025
Discovery of a Novel Series of <i>iso</i>-Indolinone-Based Glutarimides as Highly Efficacious and Selective IKZF2 Molecular Glue Degraders
Xuqing Zhang, Harshil Dhruv, Qiaolin Deng, et al.
Journal of Medicinal Chemistry
|
March 20, 2010
Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication
Renato T Skerlj, Gary J Bridger, Al Kaller, et al.
Journal of Medicinal Chemistry
|
March 30, 2011
A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment
Qian Cai, Haiying Sun, Yuefeng Peng, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 8, 2011
Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication
Renato Skerlj, Gary Bridger, Ernest McEachern, et al.
Page
of 50